News & Updates

Dimethyl fumarate bests interferon β-1a in paediatric-onset multiple sclerosis
Dimethyl fumarate bests interferon β-1a in paediatric-onset multiple sclerosis
10 Oct 2022

The use of dimethyl fumarate (DMF) in the treatment of children with paediatric-onset multiple sclerosis (POMS) appears to produce more favourable effects than interferon β-1a (IFNβ-1a), with those on DMF being less likely to have new or newly enlarging lesions and experience relapse, according to data from the open-label CONNECT study.

Dimethyl fumarate bests interferon β-1a in paediatric-onset multiple sclerosis
10 Oct 2022
HBsAg seroclearance tied to lower recurrence risk of HBV-related hepatocellular carcinoma
HBsAg seroclearance tied to lower recurrence risk of HBV-related hepatocellular carcinoma
10 Oct 2022
Pan-enteric capsule endoscopy accurately diagnoses IBD
Pan-enteric capsule endoscopy accurately diagnoses IBD
10 Oct 2022